home All News open_in_new Full Article

Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial

Kane to work with the University of Miami to study DispersinB® Acne Cleanser in mild to moderate Acne Vulgaris WINNIPEG, Manitoba, March 13, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces today that it has received approval from the Internal Review Board (“IRB”) of the University of Miami Health System […]


today 3 h. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Society
attach_file Other
attach_file Other
attach_file Economics
attach_file Politics
attach_file Events
attach_file Science
attach_file Society
attach_file Events
attach_file Economics
attach_file Other
attach_file Economics
attach_file Events
attach_file Other
attach_file Events
attach_file Other
attach_file Other


ID: 1679779824
Add Watch Country

arrow_drop_down